Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model

4Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Increasing evidence supports a role for deficient Wnt signaling in Alzheimer’s disease (AD). Studies reveal that the secreted Wnt antagonist Dickkopf-3 (DKK3) colocalizes to amyloid plaques in AD patients. Here, we investigate the contribution of DKK3 to synapse integrity in healthy and AD brains. Our findings show that DKK3 expression is upregulated in the brains of AD subjects NL-G-F/ and that DKK3 protein levels increase at early stages in the disease. In hAPP-J20 and hAPP NL-G-F mouse AD models, extracellular DKK3 levels are increased and DKK3 accumulates at dystro-phic neuronal processes around plaques. Functionally, DKK3 triggers the loss of excitatory synapses through blockade of the Wnt/GSK3β signaling with a concomitant increase in inhibitory synapses via activation of the Wnt/JNK pathway. In contrast, DKK3 knockdown restores synapse number and memory in hAPP-J20 mice. Collectively, our findings identify DKK3 as a novel driver of synaptic defects and memory impairment in AD.

Cite

CITATION STYLE

APA

Martin Flores, N., Podpolny, M., McLeod, F., Workman, I., Crawford, K., Ivanov, D., … Salinas, P. C. (2024). Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model. ELife, 12. https://doi.org/10.7554/eLife.89453

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free